These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7064590)

  • 1. [Calcium metabolism before and during hemodialysis].
    Buchali K; Seeger W; Müller P
    Z Urol Nephrol; 1982 Jan; 75(1):31-4. PubMed ID: 7064590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
    Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
    Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an optimum dialysis fluid calcium concentration on calcium mass transfer during maintenance hemodialysis.
    Carney SL; Gillies AH
    Clin Nephrol; 1985 Jul; 24(1):28-30. PubMed ID: 4017296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Busulfan clearance in renal failure and hemodialysis.
    Ullery LL; Gibbs JP; Ames GW; Senecal FM; Slattery JT
    Bone Marrow Transplant; 2000 Jan; 25(2):201-3. PubMed ID: 10673681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total body retention and intestinal absorption of orally administered calcium-47 in chronic hemodialysis patients.
    Rubinger D; Ronen M; Schachner E; Czaczkes JW
    Isr J Med Sci; 1980 Mar; 16(3):165-8. PubMed ID: 7390756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinin kinetics during different dialysis protocols with AN69 dialyser in ACEI-treated patients.
    Van der Niepen P; Sennesael JJ; Verbeelen DL
    Nephrol Dial Transplant; 1995; 10(9):1689-95. PubMed ID: 8559490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
    Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
    Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
    Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
    Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
    Suzuki T; Kanno Y; Nakamoto H; Okada H; Sugahara S; Suzuki H
    Adv Perit Dial; 2003; 19():148-54. PubMed ID: 14763052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
    Lee CT; Tsai YC; Ng HY; Su Y; Lee WC; Lee LC; Chiou TT; Liao SC; Hsu KT
    J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin secretion in chronic renal patients treated with hemodialysis.
    Gozariu L; Manasia M; Paţiu IM; Vlăduţiu D; Barabas E; Spânu C; Căprioară M
    Endocrinologie; 1981; 19(4):253-6. PubMed ID: 7323650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of phosphorus during hemodialysis and the calculation of its effective dialysis clearance.
    Schück O; Kaslikov J
    Clin Nephrol; 1997 Jun; 47(6):379-83. PubMed ID: 9202868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of changes in levels of calcium, phosphate and magnesium during hemodialysis on autonomic system reactivity as measured by heart rate variability analysis].
    Buda S; Stompór T; Sułowicz W; Kopeć J; Szymczakiewicz-Multanowska A; Janion M
    Przegl Lek; 2000; 57(6):340-5. PubMed ID: 11107869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of high-flux hemodialysis on dialysis-associated amyloidosis.
    Ayli M; Ayli D; Azak A; Yüksel C; Atilgan G; Dede F; Akalin T; Abayli E; Camlibel M
    Ren Fail; 2005; 27(1):31-4. PubMed ID: 15717632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.